[1]
|
Ochoa, J.L. (2009) Neuropathic Pain: Redefinition and a Grading System for Clinical and Research Purposes. Neurology, 72, 1282-1283. https://doi.org/10.1212/01.wnl.0000346325.50431.5f
|
[2]
|
Borzan, J. and Meyer, R.A. (2009) Neuropathic Pain. In: Squire, L.R., Ed., Encyclopedia of Neuroscience, Academic Press, Cambridge, 749-757. https://doi.org/10.1016/B978-008045046-9.01926-4
|
[3]
|
Scholz, J. and Woolf, C.J. (2007) The Neuropathic Pain Triad: Neurons, Immune Cells and Glia. Nature Neuroscience, 10, 1361-1368. https://doi.org/10.1038/nn1992
|
[4]
|
Singh, S., Krukowski, K., Laumet, G., Weis, D., Alexander, J., Heijnen, C. and Kavelaars, A. (2022) CD8+ T Cell- Derived IL-13 Increases Macrophage IL-10 to Resolve Neuropathic Pain. JCI in-sight, 7, e154194.
https://doi.org/10.1172/jci.insight.154194
|
[5]
|
Domoto, R., Sekiguchi, F., Tsubota, M. and Kawabata, A. (2021) Macrophage as a Peripheral Pain Regulator. Cells, 10, Article 1881. https://doi.org/10.3390/cells10081881
|
[6]
|
Hogan, Q.H. (2010) Labat Lecture: The Primary Sensory Neuron: Where It Is, What It Does, and Why It Matters. Regional Anesthesia and Pain Medicine, 35, 306-311. https://doi.org/10.1097/AAP.0b013e3181d2375e
|
[7]
|
Finnerup, N., Kuner, R. and Jensen, T. (2021) Neuropathic Pain: From Mechanisms to Treatment. Physiological reviews, 101, 259-301. https://doi.org/10.1152/physrev.00045.2019
|
[8]
|
Oishi, Y. and Manabe, I. (2018) Macrophages in Inflammation, Repair and Regeneration. International Immunology, 30, 511-528. https://doi.org/10.1093/intimm/dxy054
|
[9]
|
Simeoli, R., Montague, K., Jones, H.R., Castaldi, L., Chambers, D., Kelleher, J.H., Vacca, V., Pitcher, T., Grist, J., Al-Ahdal, H., Wong, L.F., Perretti, M., Lai, J., Mouritzen, P., Heppenstall, P. and Malcangio, M. (2017) Exosomal Cargo Including MicroRNA Regulates Sensory Neuron to Macrophage Com-munication after Nerve Trauma. Nature Communications, 8, Article No. 1778. https://doi.org/10.1038/s41467-017-01841-5
|
[10]
|
Hu, P. and McLachlan, E.M. (2003) Distinct Functional Types of Macrophage in Dorsal Root Ganglia and Spinal Nerves Proximal to Sciatic and Spinal Nerve Transections in the Rat. Experimental Neurology, 184, 590-605.
https://doi.org/10.1016/S0014-4886(03)00307-8
|
[11]
|
Hu, P. and McLachlan, E.M. (2002) Macrophage and Lym-phocyte Invasion of Dorsal Root Ganglia after Peripheral Nerve Lesions in the Rat. Neuroscience, 112, 23-38. https://doi.org/10.1016/S0306-4522(02)00065-9
|
[12]
|
Hu, P., Bembrick, A.L., Keay, K.A. and McLachlan, E.M. (2007) Immune Cell Involvement in Dorsal Root Ganglia and Spinal Cord after Chronic Constriction or Transection of the Rat Sciatic Nerve. Brain, Behavior, and Immunity, 21, 599-616. . https://doi.org/10.1016/j.bbi.2006.10.013
|
[13]
|
Yu, X., Liu, H., Hamel, K.A., Morvan, M.G., Yu, S., Leff, J., Guan, Z., Braz, J.M. and Basbaum, A.I. (2020) Dorsal Root Ganglion Macrophages Contribute to Both the Initiation and Per-sistence of Neuropathic Pain. Nature Communications, 11, Article No. 264. https://doi.org/10.1038/s41467-019-13839-2
|
[14]
|
Mashaghi, A., Marmalidou, A., Tehrani, M., Grace, P.M., Pot-houlakis, C. and Dana, R. (2016) Neuropeptide Substance P and the Immune Response. Cellular and Molecular Life Sciences, 73, 4249-4264.
https://doi.org/10.1007/s00018-016-2293-z
|
[15]
|
Feickert, M. and Burckhardt, B. (2019) Substance P in Cardio-vascular Diseases—A Bioanalytical Review. Clinica Chimica Acta, 495, 501-506. https://doi.org/10.1016/j.cca.2019.05.014
|
[16]
|
Sun, J., Ramnath, R.D., Zhi, L., Tamizhselvi, R. and Bhatia, M. (2008) Substance P Enhances NF-κB Transactivation and Chemokine Response in Murine Macrophages via ERK1/2 and p38 MAPK Signaling Pathways. American Journal of Physiology—Cell Physiology, 294, C1586-C1596. https://doi.org/10.1152/ajpcell.00129.2008
|
[17]
|
Smiley, S.T., King, J.A. and Hancock, W.W. (2001) Fibrinogen Stimulates Macrophage Chemokine Secretion through Toll-Like Receptor 4. The Journal of Immunology, 167, 2887-2894. https://doi.org/10.4049/jimmunol.167.5.2887
|
[18]
|
Ma, W., Chabot, J.G., Vercauteren, F. and Quirion, R. (2010) Injured Nerve-Derived COX2/PGE2 Contributes to the Maintenance of Neuropathic Pain in Aged Rats. Neu-robiology of Aging, 31, 1227-1237.
https://doi.org/10.1016/j.neurobiolaging.2008.08.002
|
[19]
|
Du, S., Wu, S., Feng, X., Wang, B., Xia, S., Liang, L., Zhang, L., Govindarajalu, G., Bunk, A., Kadakia, F., Mao, Q., Guo, X., Zhao, H., Berkman, T., Liu, T., Li, H., Stillman, J., Bekker, A., Davidson, S. and Tao, Y. (2022) A Nerve Injury-Specific Long Noncoding RNA Promotes Neuropathic Pain by Increasing Ccl2 Expression. The Journal of Clinical Investigation, 132, e153563. https://doi.org/10.1172/JCI153563
|
[20]
|
Brennan, F.H., Gordon, R., Lao, H.W., Biggins, P.J., Taylor, S.M., Frank-lin, R.J.M., Woodruff, T.M. and Ruitenberg, M.J. (2015) The Complement Receptor C5aR Controls Acute Inflammation and Astrogliosis following Spinal Cord Injury. Journal of Neuroscience, 35, 6517-6531. https://doi.org/10.1523/JNEUROSCI.5218-14.2015
|
[21]
|
Shutov, L.P., Warwick, C.A., Shi, X., Gnanasekaran, A., Shepherd, A.J., Mohapatra, D.P., Woodruff, T.M., David Clark, J. and Usachev, Y.M. (2016) The Complement System Component C5a Produces Thermal Hyperalgesia via Macrophage-to-Nociceptor Signaling That Requires NGF and TRPV1. Journal of Neuroscience, 36, 5055-5070.
https://doi.org/10.1523/JNEUROSCI.3249-15.2016
|
[22]
|
Okamura, A., Rakugi, H., Ohishi, M., Yanagitani, Y., Takiuchi, S., Moriguchi, K., Fennessy, P.A., Higaki, J. and Ogihara, T. (1999) Upregulation of Renin-Angiotensin Sys-tem during Differentiation of Monocytes to Macrophages. Journal of Hypertension, 17, 537-545. https://doi.org/10.1097/00004872-199917040-00012
|
[23]
|
Shepherd, A.J., Mickle, A.D., Golden, J.P., Mack, M.R., Halabi, C.M., De Kloet, A.D., Samineni, V.K., Kim, B.S., Krause, E.G., Gereau, R.W. and Mohapatra, D.P. (2018) Macrophage Angiotensin II Type 2 Receptor Triggers Neuropathic Pain. Proceedings of the National Academy of Sci-ences of the United States of America, 115, E8057-E8066.
https://doi.org/10.1073/pnas.1721815115
|
[24]
|
Danser, A.H.J. and Anand, P. (2014) The Angiotensin II Type 2 Receptor for Pain Control. Cell, 157, 1504-1506.
https://doi.org/10.1016/j.cell.2014.05.030
|
[25]
|
Smith, M.T., Woodruff, T.M., Wyse, B.D., Muralidharan, A. and Walther, T. (2013) A Small Molecule Angiotensin II Type 2 Receptor (AT2R) Antagonist Produces Analgesia in a Rat Model of Neuropathic Pain by Inhibition of p38 Mitogen-Activated Protein Kinase (MAPK) and p44/p42 MAPK Acti-vation in the Dorsal Root Ganglia. Pain Medicine, 14, 1557-1568. https://doi.org/10.1111/pme.12157
|
[26]
|
Shepherd, A.J., Copits, B.A., Mickle, A.D., Karlsson, P., Kadunganattil, S., Haroutounian, S., Tadinada, S.M., De Kloet, A.D., Valtcheva, M.V., McIlvried, L.A., Sheahan, T.D., Jain, S., Ray, P.R., Usachev, Y.M., Dussor, G., Krause, E.G., Price, T.J., Gereau, R.W. and Mohapatra, D.P. (2018) Angiotensin II Trig-gers Peripheral Macrophage-to-Sensory Neuron Redox Crosstalk to Elicit Pain. Journal of Neuroscience, 38, 7032-7057.
https://doi.org/10.1523/JNEUROSCI.3542-17.2018
|
[27]
|
Kallenborn-Gerhardt, W., Hohmann, S.W., Syhr, K.M.J., Schröder, K., Sisignano, M., Weigert, A., Lorenz, J.E., Lu, R., Brüne, B., Brandes, R.P., Geisslinger, G. and Schmidtko, A. (2014) Nox2-Dependent Signaling between Macrophages and Sensory Neurons Contributes to Neuropathic Pain Hypersensitivity. Pain, 155, 2161-2170.
https://doi.org/10.1016/j.pain.2014.08.013
|
[28]
|
Mao, Q., Guo, X., Zhao, H., Berkman, T., Liu, T., Li, H., Stillman, J., Bekker, A., Davidson, S., Tao, Y., et al. (2022) A Nerve Injury-Specific Long Noncoding RNA Promotes Neuro-pathic Pain by Increasing Ccl2 Expression. The Journal of Clinical Investigation, 132, e153563. https://doi.org/10.1172/JCI153563
|
[29]
|
Chen, O., Donnelly, C.R. and Ji, R.R. (2020) Regulation of Pain by Neu-ro-Immune Interactions between Macrophages and Nociceptor Sensory Neurons. Current Opinion in Neurobiology, 62, 17-25.
https://doi.org/10.1016/j.conb.2019.11.006
|
[30]
|
Dansereau, M., Midavaine, É., Bégin-Lavallée, V., Belkouch, M., Beaudet, N., Longpré, J., Mélik-Parsadaniantz, S. and Sarret, P. (2021) Mechanistic Insights into the Role of the Chemo-kine CCL2/CCR2 Axis in Dorsal Root Ganglia to Peripheral Inflammation and Pain Hypersensitivity. Journal of Neu-roinflammation, 18, Article No. 79.
https://doi.org/10.1186/s12974-021-02125-y
|
[31]
|
Liu, T., Gao, Y.J. and Ji, R.R. (2012) Emerging Role of Toll-Like Receptors in the Control of Pain and Itch. Neuroscience Bulletin, 28, 131-144. https://doi.org/10.1007/s12264-012-1219-5
|
[32]
|
Bettoni, I., Comelli, F., Rossini, C., Granucci, F., Giagnoni, G., Peri, F. and Costa, B. (2008) Glial TLR4 Receptor as New Target to Treat Neuropathic Pain: Efficacy of a New Receptor Antagonist in a Model of Peripheral Nerve Injury in Mice. GLIA, 56, 1312-1319. https://doi.org/10.1002/glia.20699
|
[33]
|
Li, Y., Xia, Y., Yin, S., Wan, F., Hu, J., Kou, L., Sun, Y., Wu, J., Zhou, Q., Huang, J., Xiong, N. and Wang, T. (2021) Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson’s Disease. Frontiers in Immunology, 12, 719807. https://doi.org/10.3389/fimmu.2021.719807
|
[34]
|
Shi, X.Q., Zekki, H. and Zhang, J. (2011) The Role of TLR2 in Nerve Injury-Induced Neuropathic Pain Is Essentially Mediated through Macrophages in Peripheral Inflammatory Re-sponse. GLIA, 59, 231-241.
https://doi.org/10.1002/glia.21093
|
[35]
|
Luo, X., Huh, Y., Bang, S., He, Q., Zhang, L., Matsuda, M. and Ji, R.R. (2019) Macrophage Toll-Like Receptor 9 Contributes to Chemotherapy-Induced Neuropathic Pain in Male Mice. The Journal of Neuroscience, 39, 6848-6864.
https://doi.org/10.1523/JNEUROSCI.3257-18.2019
|
[36]
|
Bruno, K., Woller, S.A., Miller, Y.I., Yaksh, T.L., Wal-lace, M., Beaton, G. and Chakravarthy, K. (2018) Targeting Toll-Like Receptor-4 (TLR4)—an Emerging Therapeutic Target for Persistent Pain States. Pain, 159, 1908-1915.
https://doi.org/10.1097/j.pain.0000000000001306
|
[37]
|
Olona, A., Hateley, C., Muralidharan, S., Wenk, M., Torta, F. and Behmoaras, J. (2021) Sphingolipid Metabolism during Toll-Like Receptor 4 (TLR4)-Mediated Macrophage Acti-vation. British Journal of Pharmacology, 178, 4575-4587.
https://doi.org/10.1111/bph.15642
|
[38]
|
Kawasaki, T. and Kawai, T. (2014) Toll-Like Receptor Signaling Pathways. Frontiers in Immunology, 5, Article 112681.
https://doi.org/10.3389/fimmu.2014.00461
|
[39]
|
Tomita, S., Sekiguchi, F., Kasanami, Y., Naoe, K., Tsubota, M., Wake, H., Nishibori, M. and Kawabata, A. (2020) Cav3.2 Overexpression in L4 Dorsal Root Ganglion Neurons after L5 Spinal Nerve Cutting Involves Egr-1, USP5 and HMGB1 in Rats: An Emerging Signaling Pathway for Neuropathic Pain. European Journal of Pharmacology, 888, Article ID: 173587. https://doi.org/10.1016/j.ejphar.2020.173587
|
[40]
|
García-Caballero, A., Gadotti, V.M., Stemkowski, P., Weiss, N., Souza, I.A., Hodgkinson, V., Bladen, C., Chen, L., Hamid, J., Pizzoccaro, A., Deage, M., François, A., Bourinet, E. and Zamponi, G.W. (2014) The Deubiquitinating Enzyme USP5 Modulates Neuropathic and Inflammatory Pain by Enhanc-ing Cav3.2 Channel Activity. Neuron, 83, 1144- 1158. https://doi.org/10.1016/j.neuron.2014.07.036
|
[41]
|
Sekiguchi, F., Kawara, Y., Tsubota, M., Kawakami, E., Ozaki, T., Kawaishi, Y., Tomita, S., Kanaoka, D., Yoshida, S., Ohkubo, T. and Kawabata, A. (2016) Therapeutic Potential of RQ-00311651, a Novel T-Type Ca2+ Channel Blocker, in Distinct Rodent Models for Neuropathic and Visceral Pain. Pain, 157, 1655-1665.
https://doi.org/10.1097/j.pain.0000000000000565
|
[42]
|
Zamponi, G.W., Striessnig, J., Koschak, A. and Dolphin, A.C. (2015) The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Ther-apeutic Potential. Pharmacological Reviews, 67, 821-870.
https://doi.org/10.1124/pr.114.009654
|
[43]
|
Todorovic, S.M. and Jevtovic-Todorovic, V. (2013) Neuropathic Pain: Role for Presynaptic T-Type Channels in Nociceptive Signaling. Pflügers Archiv—European Journal of Physiology, 465, 921-927.
https://doi.org/10.1007/s00424-012-1211-y
|
[44]
|
Xu, Z.Z., Kim, Y.H., Bang, S., Zhang, Y., Berta, T., Wang, F., Oh, S.B. and Ji, R.R. (2015) Inhibition of Mechanical Allodynia in Neuropathic Pain by TLR5-Mediated A-Fiber Blockade. Nature Medicine, 21, 1326-1331.
https://doi.org/10.1038/nm.3978
|
[45]
|
Das, N., Dewan, V., Grace, P.M., Gunn, R.J., Tamura, R., Tzarum, N., Wat-kins, L.R., Wilson, I.A. and Yin, H. (2016) HMGB1 Activates Proinflammatory Signaling via TLR5 Leading to Allo-dynia. Cell Reports, 17, 1128-1140.
https://doi.org/10.1016/j.celrep.2016.09.076
|
[46]
|
Hohmann, S.W., Angioni, C., Tunaru, S., Lee, S., Woolf, C.J., Offermanns, S., Geisslinger, G., Scholich, K. and Sisignano, M. (2017) The G2A Receptor (GPR132) Contributes to Oxaliplatin-Induced Mechanical Pain Hypersensitivity. Scientific Reports, 7, Article No. 446. https://doi.org/10.1038/s41598-017-00591-0
|
[47]
|
Patwardhan, A.M., Scotland, P.E., Akopian, A.N. and Har-greaves, K.M. (2009) Activation of TRPV1 in the Spinal Cord by Oxidized Linoleic Acid Metabolites Contributes to In-flammatory Hyperalgesia. Proceedings of the National Academy of Sciences of the United States of America, 106, 18820-18824. https://doi.org/10.1073/pnas.0905415106
|
[48]
|
Murakami, N., Yokomizo, T., Okuno, T. and Shimi-zu, T. (2004) G2A Is a Proton-Sensing G-Protein-Coupled Receptor Antagonized by Lysophosphatidylcholine. Journal of Biological Chemistry, 279, 42484-42491.
https://doi.org/10.1074/jbc.M406561200
|
[49]
|
Osthues, T., Zimmer, B., Rimola, V., Klann, K., Schilling, K., Mathoor, P., Angioni, C., Weigert, A., Geisslinger, G., Münch, C., Scholich, K. and Sisignano, M. (2020) The Lipid Receptor G2A (GPR132) Mediates Macrophage Migration in Nerve Injury-Induced Neuropathic Pain. Cells, 9, Article 1740. https://doi.org/10.3390/cells9071740
|
[50]
|
Kiguchi, N., Saika, F., Kobayashi, Y., Ko, M.C. and Kishioka, S. (2015) TC-2559, an α4β2 Nicotinic Acetylcholine Receptor Agonist, Suppresses the Expression of CCL3 and IL-1β through STAT3 Inhibition in Cultured Murine Macrophages. Journal of Pharmacological Sciences, 128, 83-86. https://doi.org/10.1016/j.jphs.2015.04.009
|
[51]
|
Kiguchi, N., Kobayashi, D., Saika, F., Matsuzaki, S. and Kishioka, S. (2018) Inhibition of Peripheral Macrophages by Nicotinic Acetylcholine Receptor Agonists Suppresses Spinal Micro-glial Activation and Neuropathic Pain in Mice with Peripheral Nerve Injury. Journal of Neuroinflammation, 15, Article No. 96.
https://doi.org/10.1186/s12974-018-1133-5
|
[52]
|
Santa-Cecília, F.V., Ferreira, D.W., Guimaraes, R.M., Cecilio, N.T., Fonseca, M.M., Lopes, A.H., Davoli-Ferreira, M., Kusuda, R., Souza, G.R., Nachbur, U., Alves-Filho, J.C., Teixeira, M.M., Zamboni, D.S., Cunha, F.Q. and Cunha, T.M. (2019) The NOD2 Signaling in Peripheral Macrophages Contributes to Neuropathic Pain Development. Pain, 160, 102-116. https://doi.org/10.1097/j.pain.0000000000001383
|
[53]
|
Bang, S., Xie, Y.K., Zhang, Z.J., Wang, Z., Xu, Z.Z. and Ji, R.R. (2018) GPR37 Regulates Macrophage Phagocytosis and Resolution of Inflammatory Pain. Journal of Clinical In-vestigation, 128, 3568-3582.
https://doi.org/10.1172/JCI99888
|